[Skip to Content]
[Skip to Content Landing]
June 1997

Hospitalization for Skin Disease Improves Quality of Life

Author Affiliations

Department of Dermatology and Cutaneous Surgery University of Miami School of Medicine PO Box 016250 (R-250) Miami, FL 33136

Arch Dermatol. 1997;133(6):797-798. doi:10.1001/archderm.1997.03890420143028

Inpatient dermatologic services are diminishing. A recent survey1 of dermatology residents reports that 17% do not care for hospitalized patients and that less than 1% of residents care for 60 or more hospitalized patients per month. One reason for this decrease is the increasing pressure to contain medical costs. Stringent guidelines have been set up for hospital admission, length of stay, and intensity of care, all encompassed in a specific diagnostic related group that represents a certain sum for a given diagnosis. Despite these firm criteria, few objective tests are used routinely to assess the outcome, effectiveness, or cost of dermatologic hospitalization.

One outcome measure is the Psoriasis Area and Severity Index, which is often used to quantify the effectiveness of treatments for psoriasis.2 In addition, a patient-oriented measure of outcome, the Dermatology Life Quality Index, and other depression and anxiety tests can be used to measure objectively

First Page Preview View Large
First page PDF preview
First page PDF preview